VICKI is an IoT self-checkout solution for regulated retail, powered by artificial intelligence, with secure data storage and verification

Chemesis International Inc. (CSE:CSI)(OTC:CADMF)(FRA:CWAA) (the “Company” or “Chemesis”), announces its initial deployment of its VICKI Artificial Intelligence Self-Checkout Solutions at Atlanta International Airport, the world’s most efficient and busiest airport, with over 110 million passengers in 2019.[1


In collaboration with Business Traveler Services, Inc., a minority-owned airport concessionaire of Atlanta International Airport, Chemesis International with its partner ViaTouch Media Inc, has launched branded CBD automated retail stores in Concourses A & D. Under our retail brand, Green Spirit Rx, which deploys unattended retail stores, offering consumers CBD products and Personal Protective Equipment.

Through advanced technology leveraging artificial intelligence, video and voice education, creates a strong consumer engagement experience. Green Spirit Rx brings the highest quality, certified brands to market with the ability for consumers to benefit while they are on the go with travel size personal care packages. The VICKI was initially deployed prior to the pandemic, serving as a proof of concept for the Company’s unattended route to market. Chemesis and its management team are now confident in the ability to scale this retail channel throughout airports, shopping centres, arenas, and other high traffic areas.

“At Chemesis International, we believe a safe, informed consumer experience gives our consumers the ability to interact and transact in a manner in which they prefer to build a relationship with our brands, in this category. The on the go consumer depends on proximity and ease of transaction as a requirement to capture their share of wallet. We believe we are best positioned to bring our brands closer to the consumer under this platform”, says Josh Rosenberg, President of Chemesis.

“Business Traveler Services was the first company to understand the demand for CBD products within the travel sector. It established the first CBD retail store in any US Airport at Hartsfield-Jackson Atlanta International Airport. Chemesis has proven they understand our consumers, represent certified products, and leveraging the right technology to meet our consumer needs. Early results support our decision to expand this relationship and we look forward to being a preferred outlet for our travelers”, says Anita Leopold, partner of Business Traveler Services.

For more information regarding VICKI, please visit, https://getvicki.com

On Behalf of The Board of Directors
Josh Rosenberg
President

About Chemesis International Inc.

Chemesis International Inc. is a vertically integrated U.S. Multi-State and Multi-National Operator.

The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. Chemesis leverages a portfolio of brands to develop strong brand loyalty and customer retention. The Company is focused on scalable growth within its business operations; this includes its retail strategy of coalescing dispensary and alternate routes to market.

Chemesis and its team are committed to building a strong unattended and attended retail model for the cannabis market across the United States and Puerto Rico. Chemesis’ retail brand, Green Spirit Rx, will continue to provide consumers with industry-leading technology, the most sought-after products and education.

Investor Relations:

ir@chemesis.com
1 (604) 398-3378

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing, including with respect to the Company’s expectations regarding its supply and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected, including, but not limited to, in relation to executing on and maintaining its supply and distribution arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

[1] The Busiest Airport in the World 2018

View source version on accesswire.com:
https://www.accesswire.com/608666/Chemesis-International-Inc-Announces-Initial-Deployment-of-its-VICKI-Artificial-Intelligence-Self-Checkout-Solution-at-Atlanta-International-Airport

News Provided by ACCESSWIRE via QuoteMedia

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES /

Funds will be used for enhancements to manufacturing facility, in preparation for launch of infused beverages in Canadian market

Keep reading... Show less

Recreational cannabis sales in Canada are on the rise, according to new Statistics Canada figures.

Also this past trading week, a cannabis producer in Canada was forced to make various staff layoffs.

Keep reading... Show less

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com .

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Third Quarter Earnings Conference Call on Thursday, November 5, 2020 at 8:30 a.m. EST. Cronos Group’s senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations . The webcast of the call will be archived for replay on the Company’s website.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces that it has added Dr. David Brady as a member of its Advisory Board. Dr. Brady will act as a strategic advisor to the company in the area of developing and bringing to market superior science based functional nutraceutical product.

“The addition of Dr. Brady to our Advisory Board adds further credibility to the science behind our products such as VINIA® which is currently being sold in Israel and will be launched in the US in Q1 2021, as well as our unique pipeline of superfruits nutraceutical products,” stated BioHarvest Sciences CEO Ilan Sobel. “We look forward to embracing Dr. Brady’s wealth of clinical experience and knowledge of the industry and we are confident he will make a significant contribution to ensuring that we continue to deliver superior health and wellness solutions for our customers with our disruptive BioFarming technology. We will continue to assemble the best team of advisors to bring the benefits of our BioFarming technology to the world.” Dr. David Brady added: “I am honoured to join this exciting journey that BHSC has embarked on by applying its disruptive BioFarming technology to the nutraceuticals market and I look forward to working with the talented management team to bring superior science-based nutraceutical products to market”.

Keep reading... Show less